EMBRACE-OBS: Single-Site Observational Registry of Patient-Reported Outcomes Following MMA Embolization for Migraine

Part of paid clinical trials in Tacoma, Washington.

Sponsor
Cortex Neurovascular
Study ID
NCT07652034
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Chronic Migraine Headache
  • Migraine
  • Migraine Disorders

Eligibility Criteria

Sex
ALL
Age
18 Years - 64 Years
Healthy Volunteers
Not accepted

Interventions

  • Middle Meningeal Artery Embolization — PROCEDURE
    Middle meningeal artery (MMA) embolization performed as part of routine clinical care at the discretion of the treating physician. The procedure is independent of study participation and is not assigned by the study protocol. The research activity consists solely of accessing and analyzing data already documented through routine clinical care.

Study Details

EMBRACE-OBS is the first phase of the EMBRACE research program. This single-site observational registry accesses and analyzes patient-reported outcome data already collected through routine clinical care from adults with migraine who have undergone or plan to undergo middle meningeal artery (MMA) embolization. The study describes changes in headache frequency, headache severity, medication use, migraine-related disability, quality of life, and reported adverse events over time without influencing clinical care.

Key Dates

Start date
Jul 1, 2026
Status verified
Jun 2026
Primary completion
Jun 1, 2028
Completion
Jun 1, 2028

Study Design

Enrollment
50 participants (estimated)

Arms

  • Arm: Migraine Patients Undergoing MMA Embolization
    Adults aged 18 to 64 years with a diagnosis of migraine who have undergone or plan to undergo middle meningeal artery (MMA) embolization as part of routine clinical care. Participants are enrolled in an observational registry that accesses and analyzes clinical and patient-reported outcome data already documented through routine care. Study participation does not influence clinical management, procedural technique, device selection, or follow-up.

Primary Outcome Measure

Change in Patient-Reported Headache Frequency [ Time Frame: Baseline and 12 Months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Cortex Neurovascular / TRA UnionTacomaWashington98405
Dennis Wang, MD
[email protected]
253-284-0841
[email protected]
Dennis O Wang, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Tacoma, WA

By condition
Migraine
By specialty
Neurology
By research site
Cortex Neurovascular / TRA Union· Tacoma, WA

Related Studies